President Donald Trump called for legislation to lower drugs prices in the State of the Union address on Tuesday. He said drug companies, insurers, and hospitals should be required to disclose prices to foster competition. Trump also touched on the prices Americans pay for drugs versus people in other countries. (CNBC)

Merck CEO Ken Frazier said he is planning to testify at a Senate Finance Committee hearing on drug prices. The committee re-invited pharma CEOs from Merck, AbbVie, AstraZeneca, Bristol-Myers Squibb, Johnson & Johnson, Pfizer, and Sanofi to testify after they did not attend a hearing last month. (Reuters)

The Canadian drug lobby has offered billions in price cuts in the face of a government crackdown on prices. It offered to give up $6.6 billion in revenue over 10 years and freeze prices or reduce the cost of treating rare diseases. The Canadian government planned to expand its drug watchdog, the Patented Medicine Prices Review Board, to reduce the cost of prescription drugs. (Reuters)

Alphabet’s Verily life sciences division is building a rehab campus in Dayton, Ohio, in a technology-focused effort to combat the opioid epidemic. The Alphabet division is partnering with Kettering Health Network and Premier Health to create a nonprofit called OneFifteen. The campus will offer both inpatient and outpatient care. (CNBC)

The Trump administration has launched a campaign to end HIV by 2030. The program will focus on targeting areas where new infections happen and getting highly effective drugs to people at risk. Health and Human Services Secretary Alex Azar briefed members of the press on the plans before the State of the Union. (Associated Press)